Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ImExHS Limited ( (AU:IME) ) has provided an announcement.
IMEXHS Limited reported a 34.5% increase in revenue for the year ending December 31, 2024, reaching $26.45 million. Despite this growth, the company experienced a 41% reduction in its loss from ordinary activities after tax, amounting to $2.63 million. The comprehensive loss for the year increased significantly to $3.24 million, compared to the previous year’s $0.75 million. The company did not declare any dividends for the current or previous financial periods. A notable development for IMEXHS is its 97% interest in a joint operation to facilitate a new radiology contract with Colombia’s National Police Hospital, which may impact its market positioning and stakeholder interests.
More about ImExHS Limited
IMEXHS Limited operates in the healthcare technology industry, specializing in providing innovative imaging solutions and radiology services. The company focuses on enhancing medical imaging capabilities and has recently entered a joint operation to support a radiology contract with Colombia’s National Police Hospital.
YTD Price Performance: -5.26%
Average Trading Volume: 43,525
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$16.52M
For an in-depth examination of IME stock, go to TipRanks’ Stock Analysis page.